Aidoc, the leading clinical AI platform, announced strategic partnerships with Cercare Medical and Circle CVI to expand its neurosciences portfolio with advanced MR Perfusion and automated ASPECTS (Alberta Stroke Program Early CT Score), two valuable capabilities for stroke and complex neuro care. These partnerships advance Aidoc's mission to connect fragmented neuro workflows and accelerate high–stakes decisions.
The FDA–cleared and CE-marked partner algorithms will be fully integrated into aiOS, Aidoc's enterprise operating system for clinical AI, which enables efficient AI deployment, customizable and seamless workflows for neuro teams and robust outcome measurement. Aidoc's comprehensive neurosciences suite comprises radiology and mobile care coordination solutions for intracranial haemorrhage, vessel occlusions, CT perfusion, c-spine fractures, vertebral compression fractures and brain aneurysms. Expanding capabilities to include MR Perfusion and automated ASPECTS will empower consistent, data–driven decisions from first image through intervention and streamlines workflows across neurology, neuroradiology, neurointervention and neurosurgery.
"Our mission at Aidoc is to empower every neuro discipline by connecting fragmented workflows and accelerating critical decisions," said Tom Valent, Chief Business Officer at Aidoc. "These strategic partnerships with Cercare Medical and Circle CVI are pivotal to that commitment. By integrating their specialised expertise in MR Perfusion and ASPECTS, we're not just adding features; we're deepening our clinical insights and expanding the reach of AI to drive superior outcomes for patients with stroke and other complex neurological conditions."
The collaboration with Cercare Medical will bring advanced MR Perfusion capabilities to the Aidoc aiOS™ platform. MR Perfusion provides crucial physiological information about blood flow in the brain, essential for identifying salvageable tissue in extended-window stroke patients and for characterising brain tumours. Cercare Medical's innovative metabolic perfusion solutions — delivering high-quality perfusion maps based on proprietary biomarkers — will enable more precise and timely insights for neuro teams.
